EKF Diagnostics Holdings PLC - Cardiff-headquartered medical diagnostics company - Trading update to December 31. Expects to report full-year revenue and adjusted earnings before interest, tax, depreciation and amortisation in-line with management expectations. This reflects continued steady growth from the Point-of-Care division and β-HB sales. Reports good progress continues to be made in the Life Sciences division's fermentation capacity expansion. Full-year results will be released late-March.
Current stock price: 29.50 pence
12-month change: down 32%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Ekf Diagnostics (EKF)